8 hrs ago | News-Medical.Net
Study affirms effectiveness of medication for juvenile rheumatoid arthritis
Juvenile rheumatoid arthritis is a chronic autoimmune disease that strikes children between the ages of newborn to 16 years. via News-Medical.Net
Yesterday | PR-inside.com
Collegium Pharmaceutical Inc. Presents Clinical Data for DETERx(TM)...
The poster, entitled, "Abuse-Deterrent Properties and Pharmacokinetics of a Novel Sustained Release Formulation of Oxycodone for the Treatment of Moderate to Severe Pain", will be presented at the 27th Annual ... via PR-inside.com
Yesterday | Deseret Morning News
“I'm sure there are some people who would benefit from this. But I think the number in the population would be very, very small.”
Cephalon Inc. has failed to win a U.S. panel's backing to expand marketing of its painkiller Fentora to include patients without cancer because of concern that the narcotic would be misused. via Deseret Morning News
Wednesday | FuturePundit
Ibuprofen Cuts Alzheimer's Disease Risk?
ST. PAUL, Minn. - Long-term use of ibuprofen and other drugs commonly used for aches and pains was associated with a lower risk of Alzheimer's disease, according to a study published in the May 6, 2008, issue ... via FuturePundit
Tuesday May 6 | CBS 3 | Posted by CBS 3
Health: Alzheimer's & Ibuprofen
The popular pain reliever Ibuprofen is in over the counter drugs like Advil and Motrin. A new study of 49,000 people found that seniors who took ibuprofen daily, for five years, had a 40 percent lower risk of developing Alzheimer's.
Previous research on it has showed conflicting results, but this new study is the longest of its kind.
"The longer you were on the Ibuprofen, the odds ratio of developing Alzheimer's Disease decreased," said Dr. Angela Scicutela, Alzheimer's Expert.
Alzheimer's Disease has been linked to brain inflammation that causes a plaque substance to build up. Ibuprofen relieves pain, by lowering inflammation, which could be why it helps with Alzheimer's. Read more
Tuesday May 6 | Rehab Management
QRxPharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy
“Initial Phase 3 efficacy data demonstrated statistically significant analgesic activity at all doses tested and reinforces the potential clinical benefit and commercial value of QRxPharma's lead dual-opioid product”
"Initial Phase 3 efficacy data demonstrated statistically significant analgesic activity at all doses tested and reinforces the potential clinical benefit and commercial value of QRxPharma's lead dual-opioid ... via Rehab Management
Monday May 5 | WebMD Health News
Ibuprofen May Cut Alzheimer's Risk
“I would not prescribe ibuprofen or any NSAID based on the current data”
The long-term use of ibuprofen and possibly other nonsteroidal anti-inflammatory pain relievers may help protect against Alzheimer's disease, but it is still not clear if the risks outweigh the potential ... via WebMD Health News
Monday May 5 | Fort Collins Coloradoan
Study: More teens abusing prescription meds to get high
“Society in general sometimes gives that same message.”
For Lupe Vasquez getting high was as easy as sneaking into her parents' medicine cabinet or asking her friends to pass the pills. via Fort Collins Coloradoan
Sunday May 4 | Freshnews
TorreyPines Therapeutics Licenses Intellectual Property from Johns...
“This is breakthrough research that further illustrates the importance of glutamate receptors as a new target for a wide range of indications”
TorreyPines Therapeutics, Inc. today announced that it has signed an exclusive license agreement with Johns Hopkins University for intellectual property related to the novel use of glutamate receptor ... via Freshnews
Saturday May 3 | New Jersey Online
30 percent of nation is in pain right now
“It's very useful for policymakers interested in the pain issue”
A Princeton University study has found that nearly three out of every 10 Americans are in pain at any given time, with the poor and less educated reporting the most frequent and intense symptoms. via New Jersey Online







